Hypersensitivity of diabetic human platelets to platelet activating factor
- 1 May 1992
- journal article
- Published by Elsevier in Thrombosis Research
- Vol. 66 (2-3) , 239-246
- https://doi.org/10.1016/0049-3848(92)90194-f
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Phospholipase D in cell signalling and its relationship to phospholipase CLife Sciences, 1991
- Inositol phospholipid turnover in PAF transmembrane signallingLipids, 1991
- Decreased platelet phosphoinositide turnover and enhanced platelet activation in IDDMDiabetes, 1989
- Response to platelet‐activating factor in human platelets stored and aged in plasma. Decrease in aggregation, phosphoinositide turnover, and receptor affinityTransfusion, 1989
- Platelet activating factor-stimulated formation of inositol triphosphate in platelets and its regulation by various agents including Ca2+, indomethacin, CV-3988, and forskolinArchives of Biochemistry and Biophysics, 1985
- Inositol trisphosphate, a novel second messenger in cellular signal transductionNature, 1984
- Platelets and Diabetes MellitusNew England Journal of Medicine, 1984
- Increased arachidonic acid content in platelet phospholipids from diabetic patientsProstaglandins, Leukotrienes and Medicine, 1983
- AGEPC (platelet activating factor) induced stimulation of rabbit platelets: Effects on phosphatidylinositol, DI- and TRI-phosphoinositides and phosphatidic acid metabolismBiochemical and Biophysical Research Communications, 1982
- Increased Synthesis of Prostaglandin-E-like Material by Platelets from Patients with Diabetes MellitusNew England Journal of Medicine, 1977